Biology:MAPKAPK2

From HandWiki
Short description: Protein-coding gene in the species Homo sapiens


A representation of the 3D structure of the protein myoglobin showing turquoise α-helices.
Generic protein structure example

MAP kinase-activated protein kinase 2 is an enzyme that in humans is encoded by the MAPKAPK2 gene.[1][2][3]

Function

This gene encodes a member of the Ser/Thr protein kinase family. This kinase is regulated through direct phosphorylation by p38 MAP kinase. In conjunction with p38 MAP kinase, this kinase is known to be involved in many cellular processes including stress and inflammatory responses, nuclear export, gene expression regulation and cell proliferation. Heat shock protein HSP27 was shown to be its major direct substrate in vivo. Two transcript variants encoding two different isoforms have been found for this gene.[4]

Vascular barrier

MK2 pathway has been demonstrated to have a key role in maintaining and repairing the integrity of endothelial barrier in the lung via actin[5] and vimentin remodeling. Activation of MK2 via its phosphorylation by p38 has been shown to restore the vascular barrier[3] and repair vascular leak,[6] associated with over 60 medical conditions, including Acute Respiratory Distress Syndrome (ARDS), a major cause of death around the world.[7]

SASP initiation

MAPKAPK2 mediates the initiation of the senescence-associated secretory phenotype (SASP) by mTOR (mechanistic target of rapamycin).[8][9] Interleukin 1 alpha (IL1A) is found on the surface of senescent cells, where it contributes to the production of SASP factors due to a positive feedback loop with NF-κB.[10][11] Translation of mRNA for IL1A is highly dependent upon mTOR activity.[12] mTOR activity increases levels of IL1A, mediated by MAPKAPK2.[10]

See also

  • SB 203580, suppresses the activation of MAPKAPK2
  • MK2-AP directly activates MAPKAPK2 independent of p38.[3]

Interactions

MAPKAPK2 has been shown to interact with:

References

  1. "The primary structure of a human MAP kinase activated protein kinase 2". Biochemical and Biophysical Research Communications 200 (2): 1118–24. April 1994. doi:10.1006/bbrc.1994.1566. PMID 8179591. 
  2. "The substrate specificity and structure of mitogen-activated protein (MAP) kinase-activated protein kinase-2". The Biochemical Journal 296 ( Pt 3) (Pt 3): 843–9. December 1993. doi:10.1042/bj2960843. PMID 8280084. 
  3. 3.0 3.1 3.2 "Anthrax lethal toxin-induced lung injury and treatment by activating MK2". Journal of Applied Physiology 119 (4): 412–9. August 2015. doi:10.1152/japplphysiol.00335.2015. PMID 26066827. 
  4. "Entrez Gene: MAPKAPK2 mitogen-activated protein kinase-activated protein kinase 2". https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=9261. 
  5. "Smooth muscle alpha-actin expression and myofibroblast differentiation by TGFbeta are dependent upon MK2". Journal of Cellular Biochemistry 100 (6): 1581–92. April 2007. doi:10.1002/jcb.21154. PMID 17163490. 
  6. "Anthrax lethal toxin disrupts the endothelial permeability barrier through blocking p38 signaling". Journal of Cellular Physiology 227 (4): 1438–45. April 2012. doi:10.1002/jcp.22859. PMID 21618534. 
  7. "Fifty Years of Research in ARDS. The Epidemiology of Acute Respiratory Distress Syndrome. A 50th Birthday Review". American Journal of Respiratory and Critical Care Medicine 195 (7): 860–870. April 2017. doi:10.1164/rccm.201609-1773CP. PMID 28157386. 
  8. "Polyphenols as Caloric-Restriction Mimetics and Autophagy Inducers in Aging Research". Nutrients 12 (5): 1344. May 2020. doi:10.3390/nu12051344. PMID 32397145. 
  9. "mTOR as a central regulator of lifespan and aging". F1000Research 8: 998. 2019. doi:10.12688/f1000research.17196.1. PMID 31316753. 
  10. 10.0 10.1 "MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation". Nature Cell Biology 17 (8): 1049–61. August 2015. doi:10.1038/ncb3195. PMID 26147250. 
  11. "Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism". Aging Cell 16 (3): 564–574. June 2017. doi:10.1111/acel.12587. PMID 28371119. 
  12. "Rapamycin and the inhibition of the secretory phenotype". Experimental Gerontology 94: 89–92. August 2017. doi:10.1016/j.exger.2017.01.026. PMID 28167236. 
  13. 13.0 13.1 "p38 Kinase-dependent MAPKAPK-2 activation functions as 3-phosphoinositide-dependent kinase-2 for Akt in human neutrophils". The Journal of Biological Chemistry 276 (5): 3517–23. February 2001. doi:10.1074/jbc.M005953200. PMID 11042204. 
  14. "Cell type-specific inhibition of the ETS transcription factor ER81 by mitogen-activated protein kinase-activated protein kinase 2". The Journal of Biological Chemistry 276 (45): 41856–61. November 2001. doi:10.1074/jbc.M106630200. PMID 11551945. 
  15. 15.0 15.1 "P66(ShcA) interacts with MAPKAP kinase 2 and regulates its activity". FEBS Letters 564 (1–2): 205–11. April 2004. doi:10.1016/S0014-5793(04)00351-5. PMID 15094067. 
  16. "MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death". Nature Cell Biology 19 (10): 1237–1247. October 2017. doi:10.1038/ncb3608. PMID 28920952. 

Further reading